Chase AIPricingFAQs
Display currency
Loading news…

Architect Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
San Diego, California, United States Founded 2023 1-10 employees For Profit

Architect Therapeutics is a developer of therapeutics that focuses on creating treatments for diseases, particularly in the field of cancer.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
2

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
27
Patents granted
2
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$163.11K

Company Info

Founded
2023
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
1
HQ
San Diego, California, United States
Region
Greater San Diego Area, West Coast, Western US

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
0
Trend (30d)
1.1
Trend (90d)
3.6

Key People at Architect Therapeutics

Co-Founder & Chairman
CEO & Co-Founder

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Architect Therapeutics

Loading news…

FAQs about Architect Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Architect Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments